ArticleFrontiers in endocrinology2025
The relationship between postoperative parathormone suppression and surgical cure in primary hyperparathyroidism.
Article in Frontiers in endocrinology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: In primary hyperparathyroidism(pHPT), suppression in other glands due to autonomy of pathological gland is frequently observed. In this retrospective study, we aimed to evaluate contribution of suppression of remaining parathyroid glands in pHPT in predicting surgical cure. Methods: We retrospectively analyzed data from patients diagnosed with pHPT and operated at our institution between 2014 and 2022. Patients who demonstrated either a decrease of more than 50% in intraoperative parathormone levels or a normal parathormone (PTH) level at the 6th postoperative hour were included. Patients were categorized into two groups based on their PTH levels at the 6th postoperative hour: those with PTH suppression (PTH < 15 ng/L) and those without (PTH > 15 ng/L). We analyzed the outcomes in terms of persistent disease and biochemical markers. Results: Among 196 patients who met the inclusion criteria, 124 exhibited PTH suppression while 72 did not. Persistent disease was significantly more common in the non-suppressed group (19.4% Conclusion: Early postoperative PTH suppression is highly associated with surgical cure. The rate of pPHPT is significantly higher in non-suppressed patients. Therefore, in follow-up strategies of postoperative patients, the possibility of a remnant pathological gland should be considered especially in those without early PTH suppression.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.